PPFIA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Here we found that PPFIA1 plays an important role in CML tumorigenesis and hypothesize that targeting PPFIA1 expression may show anti-CML activity and confer a therapeutic benefit in CML patients.